These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6219291)

  • 1. Suppression of responses to cryptococcal antigen in murine cryptococcosis.
    Robinson BE; Hall NK; Bulmer GS; Blackstock R
    Mycopathologia; 1982 Dec; 80(3):157-63. PubMed ID: 6219291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-specific immunosuppression by Cryptococcus neoformans infection.
    Blackstock R; Hall NK
    Mycopathologia; 1984 Apr; 86(1):35-43. PubMed ID: 6234468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of cryptococcal antigens on cell-mediated immunity.
    Murphy JW
    Rev Infect Dis; 1988; 10 Suppl 2():S432-5. PubMed ID: 2973118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of cell-mediated immunity in cryptococcosis. I. Induction of specific afferent T suppressor cells by cryptococcal antigen.
    Murphy JW; Moorhead JW
    J Immunol; 1982 Jan; 128(1):276-83. PubMed ID: 6172483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of natural killer cell activity and clearance of Cryptococcus neoformans from mice after adoptive transfer of splenic nylon wool-nonadherent cells.
    Hidore MR; Murphy JW
    Infect Immun; 1986 Feb; 51(2):547-55. PubMed ID: 3510981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host-etiological agent interactions in intranasally and intraperitoneally induced Cryptococcosis in mice.
    Lim TS; Murphy JW; Cauley LK
    Infect Immun; 1980 Aug; 29(2):633-41. PubMed ID: 7011980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of an in vitro-stimulated, Cryptococcus neoformans-specific second-order suppressor T cell and its precursor.
    Fidel PL; Murphy JW
    Infect Immun; 1988 May; 56(5):1267-72. PubMed ID: 2965681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of cell-mediated immunity in cryptococcosis. II. Characterization of first-order T suppressor cells (Ts1) and induction of second-order suppressor cells.
    Murphy JW; Mosley RL; Moorhead JW
    J Immunol; 1983 Jun; 130(6):2876-81. PubMed ID: 6222119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization of mice with stable, acapsular, yeast-like mutants of Cryptococcus neoformans.
    Fromtling RA; Kaplan AM; Shadomy HJ
    Sabouraudia; 1983 Jun; 21(2):113-9. PubMed ID: 6348975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of antigen-specific suppression by circulating Cryptococcus neoformans antigen.
    Murphy JW; Cox RA
    Clin Exp Immunol; 1988 Aug; 73(2):174-80. PubMed ID: 2460273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of first-order Cryptococcus-specific T-suppressor cells on induction of cells responsible for delayed-type hypersensitivity.
    Murphy JW
    Infect Immun; 1985 May; 48(2):439-45. PubMed ID: 3157646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of a macrophage-suppressive lymphokine by soluble cryptococcal antigens and its association with models of immunologic tolerance.
    Blackstock R; McCormack JM; Hall NK
    Infect Immun; 1987 Jan; 55(1):233-9. PubMed ID: 2947863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presentation of cryptococcal capsular polysaccharide (GXM) on activated antigen-presenting cells inhibits the T-suppressor response and enhances delayed-type hypersensitivity and survival.
    Blackstock R; Casadevall A
    Immunology; 1997 Nov; 92(3):334-9. PubMed ID: 9486105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro human lymphocyte responses to Cryptococcus neoformans. Evidence for primary and secondary responses in normals and infected subjects.
    Miller GP; Puck J
    J Immunol; 1984 Jul; 133(1):166-72. PubMed ID: 6373927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell response to soluble cryptococcal antigens after recovery from cryptococcal infection.
    Hoy JF; Murphy JW; Miller GG
    J Infect Dis; 1989 Jan; 159(1):116-9. PubMed ID: 2462601
    [No Abstract]   [Full Text] [Related]  

  • 16. Transfer of immunity to cryptococcosis by T-enriched splenic lymphocytes from Cryptococcus neoformans-sensitized mice.
    Lim TS; Murphy JW
    Infect Immun; 1980 Oct; 30(1):5-11. PubMed ID: 7002791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppression in experimental cryptococcosis in rats. Induction of afferent T suppressor cells to a non-related antigen.
    Sotomayor CE; Rubinstein HR; Riera CM; Masih DT
    J Med Vet Mycol; 1987 Apr; 25(2):67-76. PubMed ID: 2955089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural cellular resistance of beige mice against Cryptococcus neoformans.
    Hidore MR; Murphy JW
    J Immunol; 1986 Dec; 137(11):3624-31. PubMed ID: 3537121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of immunization with Cryptococcus neoformans cells or cryptococcal culture filtrate antigen on direct anticryptococcal activities of murine T lymphocytes.
    Muth SM; Murphy JW
    Infect Immun; 1995 May; 63(5):1645-51. PubMed ID: 7729868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro interactions of immune lymphocytes and Cryptococcus neoformans.
    Fung PY; Murphy JW
    Infect Immun; 1982 Jun; 36(3):1128-38. PubMed ID: 7047393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.